Anda | Teva Pharmaceutical Industries | Controlled Substances Act violation | 2016 | WV-AG | $1,800,000 |
Bristol-Myers Squibb Company | Bristol-Myers Squibb | consumer protection violation | 2019 | WV-AG | $1,600,000 |
Dey Inc. | Viatris | False Claims Act and related | 2004 | WV-AG | $850,000 |
Johnson and Johnson | Johnson & Johnson | consumer protection violation | 2009 | WV-AG | $4,475,000 |
Sanofi-Aventis | Sanofi | consumer protection violation | 2019 | WV-AG | $1,600,000 |
Johnson & Johnson | Johnson & Johnson | drug or medical equipment safety violation | 2020 | WV-AG | $3,900,000 |
Teva Pharmaceutical Industries | Teva Pharmaceutical Industries | off-label or unapproved promotion of medical products | 2022 | WV-AG | $83,000,000 |
Allergan | AbbVie | off-label or unapproved promotion of medical products | 2022 | WV-AG | $78,000,000 |
Janssen Pharmaceuticals | Johnson & Johnson | off-label or unapproved promotion of medical products | 2022 | WV-AG | $99,000,000 |
Amgen Inc. | Amgen | False Claims Act and related | 2008 | WI-AG | $2,000,000 |
Boehringer Ingelheim Pharmaceuticals, Inc. | Boehringer Ingelheim | False Claims Act and related | 2010 | WI-AG | $7,750,000 |
Dey, Inc. | Viatris | False Claims Act and related | 2010 | WI-AG | $2,000,000 |
Merck and Company, Inc. | Merck | False Claims Act and related | 2011 | WI-AG | $4,250,000 |
Pharmacia Corporation | Pfizer | False Claims Act and related | 2013 | WI-AG | $29,453,247 |
TAP Pharmaceutical Products, Inc. | Takeda Pharmaceutical | kickbacks and bribery | 2006 | WI-AG | $798,000 |
InterMune Inc. | Roche | Family and Medical Leave Act | 2014 | WHD | $59,085 |
Perrigo Company | Perrigo | Family and Medical Leave Act | 2014 | WHD | $15,022 |
Block Drug Company Incorporated | GlaxoSmithKline | wage and hour violation | 2011 | WHD | $352,773 |
St Jude Medical Inc | Abbott Laboratories | wage and hour violation | 2009 | WHD | $17,662 |
Abbott Laboratories Puerto Rico, Inc. | Abbott Laboratories | wage and hour violation | 2009 | WHD | $49,045 |
Biogen Idec, Inc. | Biogen | wage and hour violation | 2009 | WHD | $49,600 |
Schering Corporation | Merck | Family and Medical Leave Act | 2006 | WHD | $6,000 |
Wyeth Biopharma | Pfizer | wage and hour violation | 2005 | WHD | $40,187 |
Biogen Idec Inc. | Biogen | wage and hour violation | 2005 | WHD | $6,934 |
American Pharmaceutical Partners, Inc. | Bristol-Myers Squibb | wage and hour violation | 2004 | WHD | $160,203 |
Valmed Pharmaceutical, Inc. | Teva Pharmaceutical Industries | wage and hour violation | 2004 | WHD | $83,871 |
ExecuPharm, Inc. | Parexel International | Family and Medical Leave Act | 2017 | WHD | $5,900 |
Alere San Diego Inc. | Abbott Laboratories | wage and hour violation | 2017 | WHD | $10,572 |
Mallinckrodt Enterprises, LLC | Mallinckrodt | wage and hour violation | 2018 | WHD | $54,805 |
Johnson & Johnson | Johnson & Johnson | drug or medical equipment safety violation | 2019 | WA-AG | $9,900,000 |
Biogen Idec Inc. | Biogen | consumer protection violation | 2007 | VT-AG | $10,000 |
Otsuka America Pharmaceutical, Inc. | Otsuka Pharmaceutical | consumer protection violation | 2007 | VT-AG | $10,000 |
Pfizer | Pfizer | consumer protection violation | 2022 | VT-AG | $34,564 |
Merck Sharp & Dohme Corp. | Merck | environmental violation | 2020 | VA-ENV | $20,925 |
Merck Sharp & Dohme Corp. | Merck | environmental violation | 2019 | VA-ENV | $17,290 |
Endo Pharmaceuticals Inc. and Vintage Pharmaceuticals, LLC d/b/a Qualitest Pharmaceuticals | Endo International | drug or medical equipment safety violation | 2015 | USAO | $39,000,000 |
Novartis Pharmaceuticals | Novartis | kickbacks and bribery | 2015 | USAO | $390,000,000 |
Inspire Pharmaceuticals Inc. | Merck | off-label or unapproved promotion of medical products | 2015 | USAO | $5,900,000 |
Galena Biopharma Inc. | SELLAS Life Sciences Group | False Claims Act and related | 2017 | USAO | $7,550,000 |
Celgene Corp. | Bristol-Myers Squibb | False Claims Act and related | 2017 | USAO | $280,000,000 |
Salix Pharmaceuticals Inc. | Bausch Health | kickbacks and bribery | 2016 | USAO | $54,000,000 |
Mallinckrodt LLC | Mallinckrodt | False Claims Act and related | 2013 | USAO | $3,500,000 |
Janssen Pharmaceuticals, Inc. | Johnson & Johnson | off-label or unapproved promotion of medical products | 2013 | USAO | $410,000,000 |
Novo Nordisk Inc. | Novo Holdings A/S | False Claims Act and related | 2011 | USAO | $1,725,000 |
Synthes Inc. | Johnson & Johnson | drug or medical equipment safety violation | 2010 | USAO | $669,800 |
Forest Pharmaceuticals Inc. | AbbVie | False Claims Act and related | 2010 | USAO | $149,000,000 |
Ortho-McNeil Pharmaceutical LLC | Johnson & Johnson | drug or medical equipment safety violation | 2010 | USAO | $6,140,000 |
Biovail Pharmaceuticals Inc. | Bausch Health | kickbacks and bribery | 2009 | USAO | $24,647,876 |
Johnson & Johnson | Johnson & Johnson | Controlled Substances Act violation | 2008 | USAO | $511,000 |
Depuy Orthopaedics Inc. | Johnson & Johnson | False Claims Act and related | 2007 | USAO | $84,700,000 |
Jazz Pharmaceuticals Inc. | Jazz Pharmaceuticals | off-label or unapproved promotion of medical products | 2007 | USAO | $20,000,000 |
Purdue Frederick Company Inc. | Purdue Pharma | False Claims Act and related | 2007 | USAO | $600,000,000 |
Pharmacia & Upjohn Company Inc. | Pfizer | kickbacks and bribery | 2007 | USAO | $19,700,000 |
Pharmacia & Upjohn Company LLC | Pfizer | kickbacks and bribery | 2007 | USAO | $15,000,000 |
Schering-Plough Corporation | Merck | off-label or unapproved promotion of medical products | 2006 | USAO | $435,000,000 |
Bristol-Myers Squibb | Bristol-Myers Squibb | fraud | 2005 | USAO | $300,000,000 |
ICN Pharmaceuticals, Inc. | Bausch Health | fraud | 2001 | USAO | $5,600,000 |
Roussel Uclaf S.A. | Sanofi | drug or medical equipment safety violation | 2001 | USAO | $23,193,600 |
Abiomed, Inc. | Johnson & Johnson | False Claims Act and related | 2018 | USAO | $3,100,000 |
Allergan Inc. | AbbVie | False Claims Act and related | 2018 | USAO | $3,500,000 |
Abbott Laboratories | Abbott Laboratories | off-label or unapproved promotion of medical products | 2018 | USAO | $25,000,000 |
Sigma Aldrich Co. | Merck KGaA (EMD) | environmental violation | 2004 | USAO | $180,000 |
Sanofi-Aventis U.S., LLC | Sanofi | False Claims Act and related | 2020 | USAO | $11,850,000 |
Pacira Pharmaceuticals Inc. | Pacira BioSciences | False Claims Act and related | 2020 | USAO | $3,500,000 |
Bristol-Myers Squibb | Bristol-Myers Squibb | False Claims Act and related | 2021 | USAO | $75,000,000 |
Novo Nordisk Inc | Novo Holdings A/S | False Claims Act and related | 2022 | USAO | $6,300,000 |
Abbott Laboratories Inc. | AbbVie | False Claims Act and related | 2008 | TX-AG | $28,000,000 |
Actavis Mid-Atlantic, LLC and Actavis Elizabeth, LLC | Teva Pharmaceutical Industries | False Claims Act and related | 2011 | TX-AG | $29,230,000 |
AstraZeneca | AstraZeneca | False Claims Act and related | 2018 | TX-AG | $110,000,000 |
Boehringer Ingelheim Corp. | Boehringer Ingelheim | False Claims Act and related | 2005 | TX-AG | $10,000,000 |
Dey, Inc. | Viatris | False Claims Act and related | 2003 | TX-AG | $9,000,000 |
Endo Pharmaceuticals | Endo International | False Claims Act and related | 2013 | TX-AG | $18,170,000 |
Forest Laboratories | AbbVie | False Claims Act and related | 2013 | TX-AG | $3,000,000 |
Glenmark Generics Inc. | Glenmark Pharmaceuticals | False Claims Act and related | 2015 | TX-AG | $13,750,000 |
Johnson & Johnson | Johnson & Johnson | off-label or unapproved promotion of medical products | 2012 | TX-AG | $158,000,000 |
Mylan Laboratories Inc. | Viatris | False Claims Act and related | 2010 | TX-AG | $23,000,000 |
Novartis Pharmaceuticals | Novartis | off-label or unapproved promotion of medical products | 2012 | TX-AG | $6,638,250 |
Pfizer Inc. | Pfizer | False Claims Act and related | 2013 | TX-AG | $18,170,000 |
Purdue Frederick Co. | Purdue Pharma | False Claims Act and related | 2008 | TX-AG | $1,600,000 |
Ranbaxy Pharmaceuticals, Inc. et al. | Sun Pharmaceuticals | False Claims Act and related | 2014 | TX-AG | $17,875,000 |
Schering-Plough Corp. | Merck | False Claims Act and related | 2004 | TX-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $27,000,000 |
SmithKline Beecham Corp. | GlaxoSmithKline | False Claims Act and related | 2007 | TX-AG | $1,400,000 |
Taro Pharmaceuticals USA, Inc. | Sun Pharmaceuticals | False Claims Act and related | 2014 | TX-AG | $8,750,000 |
Watson/Schein Pharmaceuticals Inc. | AbbVie | False Claims Act and related | 2011 | TX-AG | $11,300,000 |
Lupin Pharmaceuticals, Inc. | Lupin Limited | False Claims Act and related | 2019 | TX-AG | $63,000,000 |
Teva Pharmaceutical Industries Ltd. | Teva Pharmaceutical Industries | off-label or unapproved promotion of medical products | 2022 | TX-AG | $225,000,000 |
Dr. Reddy's Laboratories | Dr. Reddy's Laboratories | False Claims Act and related | 2022 | TX-AG | $12,900,000 |
Takeda Pharmaceuticals | Takeda Pharmaceutical | False Claims Act and related | 2023 | TX-AG | $21,350,000 |
Novartis AG | Novartis | Foreign Corrupt Practices Act | 2016 | SEC | $25,000,000 |
SciClone Pharmaceuticals | SciClone Pharmaceuticals | Foreign Corrupt Practices Act | 2016 | SEC | $12,000,000 |
Bristol-Myers Squibb | Bristol-Myers Squibb | Foreign Corrupt Practices Act | 2015 | SEC | $14,000,000 |
Eli Lilly and Company | Eli Lilly | Foreign Corrupt Practices Act | 2012 | SEC | $29,398,734 |
Pfizer Inc. | Pfizer | Foreign Corrupt Practices Act | 2012 | SEC | $26,339,944 |
Wyeth LLC | Pfizer | Foreign Corrupt Practices Act | 2012 | SEC | $18,876,624 |
Johnson & Johnson | Johnson & Johnson | Foreign Corrupt Practices Act | 2011 | SEC | $48,600,000 |
Novo Nordisk A/S | Novo Holdings A/S | Foreign Corrupt Practices Act | 2009 | SEC | $9,030,149 |
Biovail Corporation | Bausch Health | accounting fraud or deficiencies | 2008 | SEC | $10,000,000 |
Elan Corporation, plc | Perrigo | accounting fraud or deficiencies | 2005 | SEC | $15,000,000 |
Bristol-Myers Squibb Company | Bristol-Myers Squibb | accounting fraud or deficiencies | 2004 | SEC | $150,000,000 |
Schering-Plough Corporation | Merck | Foreign Corrupt Practices Act | 2004 | SEC | $500,000 |
Schering-Plough Corporation | Merck | investor protection violation | 2003 | SEC | $1,000,000 |